Swedish Hypertension Open care retrospective study in men and Women (SHOW)

Journal of Human Hypertension

Volumn 25, Issue 1, 2011, Pages 32-37

  Ljungman, C ^a   Collen A C ^a   Manhem, K ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

blood pressure; gender; primary health care; women

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY HEALTH CARE; PULSE PRESSURE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SWEDEN; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIURETICS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; SWEDEN; TREATMENT OUTCOME;

EID: 78650174728     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.43     Document Type: Article

References (18)

1. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360(9343): 1347-1360. (Pubitemid 35341298)
2. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28(12): 1462-1536.
3. Hedblad B, Nerbrand C, Ekesbo R, Johansson L, Midlov P, Brunkstedt I et al. High blood pressure despite treatment: Results from a cross-sectional primary healthcare-based study in southern Sweden. Scand J Prim Health Care 2006; 24(4): 224-230. (Pubitemid 44836164)
4. Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J 2008; 29(21): 2669-2680.
5. Ljungman C, Mortensen L, Kahan T, Manhem K. Treatment of mild to moderate hypertension by gender perspective: A systematic review. J Women's Health 2009; 18(7): 1049-1062.
6. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25(6): 1105-1187. (Pubitemid 46924065)
7. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: Current outcomes and control in the community. JAMA 2005; 294(4): 466-472. (Pubitemid 41124179)
8. Erkens JA, Panneman MM, Klungel OH, den Boom G, Prescott MF, Herings RM. Differences in antihypertensive drug persistence associated with drug class and gender. Pharmacoepidemiol Drug Saf 2005; 14: 795-803. (Pubitemid 41684472)
9. Bog-Hansen E, Lindblad U, Ranstam J, Melander A, Rastam L. Antihypertensive drug treatment in a Swedish community: Skaraborg Hypertension and Diabetes Project. Pharmacoepidemiol Drug Saf 2002; 11(1): 45-54. (Pubitemid 34269597)
10. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial. Lancet 2004; 363(9426): 2022-2031. (Pubitemid 38781102)
11. Journath G, Hellenius ML, Manhem K, Kjellgren KI, Nilsson PM. Association of physician's sex with risk factor control in treated hypertensive patients from Swedish primary healthcare. J Hypertens 2008; 26(10): 2050-2056.
12. Franklin SS, Gustin Wt, Wong ND, Larson MG, Weber MA, Kannel WB et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96(1): 308-315. (Pubitemid 27298437)
13. Journath G, Hellenius ML, Petersson U, Theobald H, Nilsson PM. Sex differences in risk factor control of treated hypertensives: A national primary healthcarebased study in Sweden. Eur J Cardiovasc Prev Rehabil 2008; 15(3): 258-262.
14. Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C et al. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. JAMA 2004; 292(23): 2849-2859. (Pubitemid 39628232)
15. Liamis G, Milionis H, Elisaf M. Blood pressure drug therapy and electrolyte disturbances. Int J Clin Pract 2008; 62(10): 1572-1580.
16. Lindholm L, Agenäs I, Carlberg B, de Faire U, Hedblad B, Hjemdahl P et al. Moderately Elevated Blood Pressure. A Systematic Litterature Review 2004. Volumes 1 & 2. The Swedish Council on Technology Assessment in Health Care 2004: Stockholm. SBU-rapport 170/1, pp 1-514 & 170/2, pp 1-248.
17. Lonn E, Roccaforte R, Yi Q, Dagenais G, Sleight P, Bosch J et al. Effect of long-term therapy with ramipril in high-risk women. J Am Coll Cardiol 2002; 40(4): 693-702. (Pubitemid 34925616)
18. Jamerson K, Weber MA, Bakris GL, Dahlof B, Pitt B, Shi V et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359(23): 2417-2428.